Yachun Guo
Chengde, 067000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Discovery and Activity Evaluation of Novel Dibenzoxazepinone Derivatives as Glycogen Phosphorylase Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: November 13, 2025
Synthesis and Activity Evaluation of Novel Benzoxazepinone Derivatives as Potential Inhibitors of Glycogen Phosphorylase.
Journal: Molecules (Basel, Switzerland)
Published: September 22, 2025
A Novel 5-Chloro-N-Phenyl-1 H-Indole-2-carboxamide Derivative as a Glycogen Phosphorylase Inhibitor: Evaluating the Long-Term Drug Effects on Muscle Function for the First Time.
Journal: Molecules (Basel, Switzerland)
Published: August 14, 2024
Computational insights into novel inhibitor indole-heterocycle specific against glycogen phosphorylase isoenzymes interaction mechanism.
Journal: Future medicinal chemistry
Published: July 03, 2023
A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Validation of Target PYGB.
Journal: Molecules (Basel, Switzerland)
Published: January 01, 2023
Long-term pharmacokinetic and pharmacological evaluations of a novel indole-benzazepinone derivative on obese Type 2 diabetes mellitus.
Journal: Future medicinal chemistry
Published: September 15, 2022
A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Potential Therapeutic Effect on Cerebral Ischemia.
Journal: Molecules (Basel, Switzerland)
Published: September 04, 2022
Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity.
Journal: Future medicinal chemistry
Published: April 28, 2021
Dynamic changes of Th1 cytokines in the serum of collagen-induced arthritis in mice
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: March 11, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026